How much is RubiconMD worth in 2026?

RubiconMD has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has RubiconMD raised?

RubiconMD has raised N/A in total funding across 1 funding rounds.

RubiconMD

Enterprise Systems (Healthcare)

RubiconMD valuation and funding history | Last updated: March 10, 2020 | 1 funding rounds

Current Valuation

N/A

As of March 10, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C)

$18.0M

Last Funding

Mar 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 10, 2020	Later Stage VC (Series C)	$18.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

RubiconMD is currently valued at N/A as of March 10, 2020.

Track RubiconMD Valuation Updates

Get notified when RubiconMD raises new funding or valuation changes

Explore More Data

Detailed analysis for RubiconMD

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock RubiconMD's valuation history, funding rounds, and growth metrics.

No credit card required

What is RubiconMD Worth in 2026?

RubiconMD is a leading private company in the Enterprise Systems (Healthcare) sector. Track RubiconMD's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How RubiconMD Valuation is Determined

Private company valuations like RubiconMD's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.